Rohin Mhatre serves as Executive at REPLIGEN CORP, where they oversee executive responsibilities. Since joining the company, Rohin Mhatre has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 16, 2024 involved receiving (via award) 701 shares valued at $0.
Rohin Mhatre currently holds 3,046 shares of REPLIGEN CORP (RGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rohin Mhatre has been a net neutral trader of RGEN stock. They have purchased $0 and sold $0 worth of shares.
Rohin Mhatre's most recent insider trade was on May 16, 2024, when they sold 701 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 26, 2022 | RGEN | $0 | Award | 1,202 | $N/A | Discretionary |
| May 13, 2021 | RGEN | $0 | Award | 457 | $N/A | Discretionary |